Journal
CANCER CELL
Volume 6, Issue 5, Pages 497-506Publisher
CELL PRESS
DOI: 10.1016/j.ccr.2004.09.032
Keywords
-
Categories
Funding
- NCI NIH HHS [CA71672] Funding Source: Medline
Ask authors/readers for more resources
Autocrine Writ signaling in the mouse mammary tumor virus model was the first identified mechanism of canonical pathway activation in cancer. In search of this transformation mechanism in human cancer cells, we identified breast and ovarian tumor lines with upregulation of the uncomplexed transcriptionally active form of beta-catenin without mutations afflicting downstream components. Extracellular Writ antagonists FRP1 and DKK1 caused a dramatic downregulation of P-catenin levels in these tumor cells associated with alteration of biological properties and increased expression of epithelial differentiation markers. Colorectal carcinoma cells with knockout of the mutant P-catenin allele retained upregulated P-catenin levels, which also could be inhibited by these Writ antagonists. Together, these findings establish the involvement of autocrine Writ signaling in human cancer cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available